Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anavip vs CroFab for Crotalinae Envenomation
NCT00636116Phase 3Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- May 2008
- Primary completion
- Nov 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of crotalidae immune F(ab')2 (equine) in Crotalinae envenomation, sponsored by Instituto Bioclon S.A. de C.V.. Started May 2008; status: completed.
02
Drugs
crotalidae immune F(ab')2 (equine)
03
Conditions
Crotalinae envenomation
Beyond the preview
Go deeper on NCT00636116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636116.